Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types

Two multiplex immunoassays are routinely used to assess antibody responses in clinical trials of the 9-valent human papillomavirus (9vHPV) vaccine. The HPV6/11/16/18/31/33/45/52/58 competitive Luminex immunoassay (HPV-9 cLIA) and HPV6/11/16/18/31/33/45/52/58 total immunoglobulin G Luminex immunoassa...

Descripción completa

Detalles Bibliográficos
Autores principales: Nolan, Katrina M., Seaton, Brent, Antonello, Joseph, Zhang, Yuhua, Cook, Lauren, Delfino, Krystyn, Rubinstein, Leonard J., Cheon, Kyeongmi, Group, Thomas, Luxembourg, Alain, Dubey, Sheri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117101/
https://www.ncbi.nlm.nih.gov/pubmed/36926984
http://dx.doi.org/10.1128/msphere.00962-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117101/
https://www.ncbi.nlm.nih.gov/pubmed/36926984
http://dx.doi.org/10.1128/msphere.00962-21

Ejemplares similares